Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy

Journal of NeuroVirology

Volumn 15, Issue 5-6, 2009, Pages 351-359

  Lonergan, Roisin M ^a   Carr, Michael J ^b   De Gascun, Cillian F ^b   Costelloe, Lisa F ^a   Waters, Allison ^b   Coughlan, Suzie ^b   Duggan, Marguerite ^a   Doyle, Katie ^a   Jordan, Sinead ^a   Hutchinson, Michael W ^a   Hall, William W ^b   Tubridy, Niall J ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

BK virus; Multiple sclerosis; Natalizumab; Reactivation

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; NATALIZUMAB; VIRUS DNA;

ADULT; ARTICLE; BK VIRUS; BLOOD SAMPLING; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNE DEFICIENCY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE SCLEROSIS; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROSPECTIVE STUDY; RELAPSE; REMISSION; URINALYSIS; VIREMIA; VIRUS INFECTION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; BK VIRUS; CD4-CD8 RATIO; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PHYLOGENY; POLYOMAVIRUS INFECTIONS; RECURRENCE; TUMOR VIRUS INFECTIONS; VIREMIA; YOUNG ADULT;

BK POLYOMAVIRUS; CYTOMEGALOVIRUS; POLYOMAVIRUS;

EID: 77649131433     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280903131923     Document Type: Article

References (37)

1. Arroyo AG, Yang JT, Rayburn H, Hynes RO (1996). Differential requirements for alpha4 integrins during fetal and adult hematopoiesis. Cell 85: 997-1008.
2. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R (1986). Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 315: 230-234.
3. Behzad-Behbahani A, Klapper PE, Vallely PJ, Cleator GM, Khoo SH (2004). Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation. J Clin Virol 29: 224-229.
4. Bonig H, Wundes A, Chang KH, Lucas S, Papayannopoulou T (2008). Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab. Blood 111: 3439-3441.
5. Carr MJ, McCormack GP, Mutton KJ, Crowley B (2006). Unique BK virus non-coding control region (NCCR) variants in hematopoietic stem cell transplant recipients with and without hemorrhagic cystitis. J Med Virol 78: 485-493.
6. Chen Y, Trofe J, Gordon J, Du Pasquier RA, Roy-Chaudhury P, Kuroda MJ, Woodle ES, Khalili K, Koralnik IJ. (2006). Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 80: 3495-3505.
7. Comoli P, Binggeli S, Ginevri F, Hirsch HH. (2006). Polyomavirus- associated nephropathy: update on BK virus-specific immunity. Transpl Infect Dis 8: 86-94.
8. Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH (2009). Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199: 837-846.
9. FDA (2008). Natalizumab (marketed as Tysabri) Information.
10. Gardner SD, Field AM, Coleman DV, Hulme B (1971). New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1: 1253-1257.
11. Hirsch HH, Mohaupt M, Klimkait T (2001). Prospective monitoring of BK virus load after discontinuing siroli-mus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 184: 1494-1495.
12. Ikegaya H, Saukko PJ, Tertti R, Metsarinne KP, Carr MJ, Crowley B, Sakurada K, Zheng HY, Kitamura T, Yogo Y (2006). Identification of a genomic subgroup of BK polyomavirus spread in European populations. J Gen Virol 87: 3201-3208.
13. Kalvatchev Z, Slavov S, Shtereva M, Savova S (2008). Reactivation of Polyomavirus hominis 1 (BKV) during pregnancy and the risk of mother-to-child transmission. J Clin Virol 43: 328-329.
14. Kappos L, Bates D, Hartung HP, Havrdova E, Miller D, Polman CH, Ravnborg M, Hauser SL, Rudick RA, Weiner HL, O'Connor PW, King J, Radue EW, Yousry T, Major EO, Clifford DB (2007). Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol 6: 431-441. (Pubitemid 46551850)
15. Khalili K, White MK, Lublin F, Ferrante P, Berger JR (2007). Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology 68: 985-990.
16. Knowles WA (2002). The epidemiology of BK virus and the occurrence of antigenic and genomic subtypes. In: Human polyomaviruses: molecular and clinical perspectives. Khalili K, Stoner GL (eds). New York: Wiley-Liss, pp 527-558.
17. Kurtzke JF (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
18. Markowitz RB, Thompson HC, Mueller JF, Cohen JA, Dynan WS (1993). Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis 167: 13-20.
19. Nishimoto Y, Zheng HY, Zhong S, Ikegaya H, Chen Q, Sugimoto C, Kitamura T, Yogo Y (2007). An Asian origin for subtype IV BK virus based on phylogenetic analysis. J Mol Evol 65: 103-111.
20. Polo C, Perez JL, Mielnichuck A, Fedele CG, Niubo J, Tenorio A (2004). Prevalence and patterns of polyoma-virus urinary excretion in immunocompetent adults and children. Clin Microbiol Infect 10: 640-644.
21. Prosser SE, Orentas RJ, Jurgens L, Cohen EP, Hariharan S (2008). Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of bk virus nephritis. Transplantation 85: 185-192.
22. Ransohoff RM (2005). Natalizumab and PML. Nat Neurosci 8: 1275.
23. Ransohoff RM (2007). "Thinking without thinking" about natalizumab and PML. J Neurol Sci 259: 50-52.
24. Reploeg MD, Storch GA, Clifford DB (2001). Bk virus: a clinical review. Clin Infect Dis 33: 191-202.
25. Rodrigues C, Pinto D, Medeiros R (2007). Molecular epidemiology characterization of the urinary excretion of polyomavirus in healthy individuals from Portugal- a Southern European population. J Med Virol 79: 1194-1198.
26. Rosen S, Harmon W, Krensky AM, Edelson PJ, Padgett BL, Grinnell BW, Rubino MJ, Walker DL (1983). Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection. N Engl J Med 308: 1192-1196.
27. Sabath BF, Major EO (2002). Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy. J Infect Dis 186 (Suppl 2): S180-S186.
28. Schaffer K, Sheehy N, Coughlan S, Bergin C, Hall WW (2006). JC virus in the Irish population: significant increase of genotype 2 in immunocompromised individuals. J NeuroVirol 12: 39-46.
29. Stuve O, Marra CM, Bar-Or A, Niino M, Cravens PD, Cepok S, Frohman EM, Phillips JT, Arendt G, Jerome KR, Cook L, Grand'Maison F, Hemmer B, Monson NL, Racke MK (2006). Altered CD4 + /CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch Neurol 63: 1383-1387.
30. Sundsfjord A, Flaegstad T, Flo R, Spein AR, Pedersen M, Permin H, Julsrud J, Traavik T (1994). BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis 169: 485-490.
31. Whiley DM, Mackay IM, Sloots TP (2001). Detection and differentiation of human polyomaviruses JC and BK by LightCycler PCR. J Clin Microbiol 39: 4357-4361.
32. Wong AS, Chan KH, Cheng VC, Yuen KY, Kwong YL, Leung AY (2007). Relationship of pretransplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 44: 830-837.
33. Yao K, Gagnon S, Akhyani N, Williams E, Fotheringham J, Frohman E, Stuve O, Monson N, Racke MK, Jacobson S (2008). Reactivation of human herpesvirus-6 in natali-zumab treated multiple sclerosis patients. PLoS ONE 3: e2028.
34. Yousry TA, Major EO, Ryschkewitsch C, Fahle G, Fischer S, Hou J, Curfman B, Miszkiel K, Mueller-Lenke N, Sanchez E, Barkhof F, Radue EW, Jager HR, Clifford DB (2006). Evaluation of patients treated with natalizu-mab for progressive multifocal leukoencephalopathy. N Engl J Med 354: 924-933.
35. Zhong S, Randhawa PS, Ikegaya H, Chen Q, Zheng HY, Suzuki M, Takeuchi T, Shibuya A, Kitamura T, Yogo Y (2009). Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, European and Asian populations suggest co-migration of BKV and the human race. J Gen Virol 90: 144-152.
36. Zhong S, Zheng HY, Suzuki M, Chen Q, Ikegaya H, Aoki N, Usuku S, Kobayashi N, Nukuzuma S, Yasuda Y, Kuniyoshi N, Yogo Y, Kitamura T (2007). Age-related urinary excretion of BK polyomavirus by nonimmuno-compromised individuals. J Clin Microbiol 45: 193-198.
37. Zohren F, Toutzaris D, Klärner V, Hartung HP, Kieseier B, Haas R (2008). The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans. Blood 111: 3893-3895.